These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 37041531

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
    Williamson SR, Bunde PJ, Montironi R, Lopez-Beltran A, Zhang S, Wang M, Maclennan GT, Cheng L.
    Am J Surg Pathol; 2013 Oct; 37(10):1619-26. PubMed ID: 23797724
    [Abstract] [Full Text] [Related]

  • 23. Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma.
    Pan CC, Chung MY, Ng KF, Liu CY, Wang JS, Chai CY, Huang SH, Chen PC, Ho DM.
    J Pathol; 2008 Feb; 214(3):387-93. PubMed ID: 18085521
    [Abstract] [Full Text] [Related]

  • 24. Neoadjuvant or adjuvant sirolimus for malignant metastatic or locally advanced perivascular epithelioid cell tumors: two case reports.
    Batereau C, Knösel T, Angele M, Dürr HR, D'Anastasi M, Kampmann E, Ismann B, Bücklein V, Lindner LH.
    Anticancer Drugs; 2016 Mar; 27(3):254-8. PubMed ID: 26645891
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Malignant PEComa With Metastatic Disease at Diagnosis and Resistance to Several Chemotherapy Regimens and Targeted Therapy (m-TOR Inhibitor).
    Machado I, Cruz J, Lavernia J, Rayon JM, Poveda A, Llombart-Bosch A.
    Int J Surg Pathol; 2017 Sep; 25(6):543-549. PubMed ID: 28459168
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. HMB-45 negative multifocal malignant perivascular epithelioid cell tumor of the soft tissue responding to sirolimus: First case report from India.
    Kapoor A, Beniwal S, Singhal MK, Kumar N, Kumar V, Kumar HS.
    J Cancer Res Ther; 2015 Sep; 11(4):1036. PubMed ID: 26881640
    [Abstract] [Full Text] [Related]

  • 31. Malignant perivascular epithelioid cell tumor (PEComa) of the uterus.
    Cao B, Huang Y.
    BMC Womens Health; 2022 Dec 16; 22(1):523. PubMed ID: 36522714
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Uterine malignant perivascular epithelioid cell tumor (PEComa): Two case reports].
    El Gani-Mesrar M, Bonneau C, Michenet P, Gourvennec JB, Tabareau-Delalande F.
    Ann Pathol; 2021 Feb 16; 41(1):118-122. PubMed ID: 32646778
    [Abstract] [Full Text] [Related]

  • 34. Perivascular epithelioid cell tumor ('PEComa') of the uterus: a subset of HMB-45-positive epithelioid mesenchymal neoplasms with an uncertain relationship to pure smooth muscle tumors.
    Vang R, Kempson RL.
    Am J Surg Pathol; 2002 Jan 16; 26(1):1-13. PubMed ID: 11756764
    [Abstract] [Full Text] [Related]

  • 35. PNL2: A Useful Adjunct Biomarker to HMB45 in the Diagnosis of Uterine Perivascular Epithelioid Cell Tumor (PEComa).
    Valencia-Guerrero A, Pinto A, Anderson WJ, Trevisan G, Nucci MR, Hirsch MS.
    Int J Gynecol Pathol; 2020 Nov 16; 39(6):529-536. PubMed ID: 31851063
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.